Citadel Advisors
TELA icon

Citadel Advisors’s TELA Bio TELA Stock Holding History

Citadel Advisors’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,500
Closed -$26.2K – 14099
2025
Q2 		$26.2K Sell
13,500
-11,300
-46% -$14.8K ﹤0.01% 12038
2025
Q1 		$30.3K Buy
24,800
+21,100
+570% +$51.9K ﹤0.01% 12816
2024
Q4 		$11.2K Sell
3,700
-5,200
-58% -$14.6K ﹤0.01% 13561
2024
Q3 		$22.5K Buy
8,900
+1,200
+16% +$4.27K ﹤0.01% 12695
2024
Q2 		$36.2K Buy
7,700
+7,500
+3,750% +$39.5K ﹤0.01% 12087
2024
Q1 		$1.13K Buy
+200
New +$1.32K ﹤0.01% 14173
2023
Q4 		– Sell
-6,800
Closed -$54.4K – 15247
2023
Q3 		$54.4K Sell
6,800
-100
-1% -$929 ﹤0.01% 11660
2023
Q2 		$69.9K Buy
6,900
+6,300
+1,050% +$64.4K ﹤0.01% 11395
2023
Q1 		$6.38K Buy
+600
New +$6.62K ﹤0.01% 13813

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Citadel Advisors's TELA Position: Q1 2026 in Review

Citadel Advisors sold out of TELA Bio (TELA) in Q1 2026, closing a stake of 23,382 shares — an estimated $27.6K sold.

Citadel Advisors first reported a position in TELA in Q1 2020 and held it in 13 quarters. The position peaked at $892K in Q2 2024. 36 funds tracked by Wall St. Rank hold TELA as of Q1 2026.

  • Citadel Advisors reported no remaining TELA Bio position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 23,382 TELA Bio shares in Q1 2026, an estimated $27.6K.
  • Citadel Advisors first reported a position in TELA Bio in Q1 2020 and held it in 13 quarters.
  • Citadel Advisors's TELA Bio position peaked at $892K in Q2 2024.
  • 36 funds tracked by Wall St. Rank held TELA Bio as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.